🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the potential of high doses of rif...
Status
Completed
Location
University of Florida
Start Date
2013-09
Trial ID
NCT01408914
Treatments Being Tested
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
There is a rapidly-growing need to identify evidence-based, safe, and effec...
Status
Terminated
Location
Hospital Nossa Senhora da Conceicao CRS (12201)
Start Date
2013-07-13
Trial ID
NCT01601626
This is a phase II randomized open-label trial of high versus standard dose...
Status
Completed
Location
Masaka Regional Referral Hospital/MRC UVRI Uganda Research Unit on AIDS
Start Date
2021-05-05
Trial ID
NCT04021121
Treatments Being Tested
This study aims to evaluate the impact of a new injection-free six-to-nine ...
Status
Completed
Location
Brooklyn Chest Hospital
Start Date
2015-11-12
Trial ID
NCT02454205
The purpose of this study is to explore safety and efficacy of TMC207 admin...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-18
Trial ID
NCT02365623
Treatments Being Tested
To compared the efficacy and safety of rifampicin and rifabutin which inclu...
Status
Unknown
Location
Shanghai Public Health Clinical Center
Start Date
2018-04-15
Trial ID
NCT03478033
Treatments Being Tested
Assess the Efficacy of HUEXC030 as Add-on Excipient to Eradicate Anti-Tuber...
Status
Completed
Location
Changhua Christian Hospital
Start Date
2012-12-06
Trial ID
NCT02467608
Treatments Being Tested
The goal of this clinical trial is to compare the efficacy and safety of a ...
Status
Active Not Recruiting
Location
Beijing Chest Hospital affiliated to Capital Medical University
Start Date
2023-12-22
Trial ID
NCT06081361
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
The Third People's Hospital of Shenzhen City
Start Date
2021-01-20
Trial ID
NCT04717908
Treatments Being Tested